Elanco Animal Health
ELAN
354 hedge funds and large institutions have $7.25B invested in Elanco Animal Health in 2023 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 103 increasing their positions, 130 reducing their positions, and 50 closing their positions.
198% more call options, than puts
Call options by funds: $69M | Put options by funds: $23.2M
34% more capital invested
Capital invested by funds: $5.41B → $7.25B (+$1.83B)
18% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 50
1.37% more ownership
Funds ownership: 97.31% → 98.68% (+1.4%)
1% more funds holding
Funds holding: 350 → 354 (+4)
21% less repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 130
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$89.8M |
| 2 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$81.4M |
| 3 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
+$69.8M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$43.2M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$41.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMU
Rokos Capital Management (UK)
London,
United Kingdom
|
-$60.5M |
| 2 |
Goldman Sachs
New York
|
-$48.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$40.7M |
| 4 |
Holocene Advisors
New York
|
-$34.6M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$29.6M |
ELAN Hedge Fund Activity: Q4 2023 in Review
354 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q4 2023, worth a combined $7.25B — up 34% from $5.41B a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new ELAN positions and 50 closed out — a net gain of 9 holders — while 103 added to existing stakes and 130 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $89.8M. The largest seller was Rokos Capital Management (UK), exiting entirely with an estimated $60.5M sold.
- 354 institutional investors held Elanco Animal Health (ELAN) as of Q4 2023, up from 350 in Q3 2023.
- Funds reported $7.25B of Elanco Animal Health stock for Q4 2023, up 34% quarter-over-quarter.
- 59 funds opened new Elanco Animal Health positions in Q4 2023 and 50 closed out, a net change of +9 holders.
- The largest Elanco Animal Health buyer in Q4 2023 was Morgan Stanley, an estimated $89.8M added.
- The largest Elanco Animal Health seller in Q4 2023 was Rokos Capital Management (UK), an estimated $60.5M sold.
Based on aggregated 13F filings for Q4 2023.